Literature DB >> 10334265

Ciprofloxacin-resistant Salmonella typhi and treatment failure.

E J Threlfall, L R Ward, J A Skinner, H R Smith, S Lacey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10334265     DOI： 10.1016/s0140-6736(99)01001-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  32 in total

1.  Intermediate susceptibility to ciprofloxacin in Salmonella typhi strains in India.

Authors:  G Mehta; V S Randhawa; N P Mohapatra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-10       Impact factor: 3.267

2.  Is it time to change fluoroquinolone breakpoints for Salmonella spp.?

Authors:  Frank Møller Aarestrup; Camilla Wiuff; Kåre Mølbak; E John Threlfall
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

3.  Molecular typing and resistance analysis of travel-associated Salmonella enterica serotype Typhi.

Authors:  A Tatavarthy; R Sanderson; K Peak; G Scilabro; P Davenhill; A Cannons; P Amuso
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

4.  A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever.

Authors:  N T Chinh; C M Parry; N T Ly; H D Ha; M X Thong; T S Diep; J Wain; N J White; J J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

5.  DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.

Authors:  Kenji Hirose; Ai Hashimoto; Kazumichi Tamura; Yoshiaki Kawamura; Takayuki Ezaki; Hiroko Sagara; Haruo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 6.  Global trends in typhoid and paratyphoid Fever.

Authors:  John A Crump; Eric D Mintz
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

7.  Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.

Authors:  E J Threlfall; L R Ward
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

8.  Quinolone and cephalosporin resistance in enteric Fever.

Authors:  Malini Rajinder Capoor; Deepthi Nair
Journal:  J Glob Infect Dis       Date:  2010-09

9.  Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.

Authors:  Marianne M Lindgren; Pirkko Kotilainen; Pentti Huovinen; Saija Hurme; Susanna Lukinmaa; Mark A Webber; Laura J V Piddock; Anja Siitonen; Antti J Hakanen
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

10.  Epidemiology of Salmonella enterica serotype typhi infections in Korea for recent 9 years: trends of antimicrobial resistance.

Authors:  Sunmi Yoo; Hyunjoo Pai; Jeong-hum Byeon; Youn Ho Kang; Shukho Kim; Bok Kwon Lee
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.